Orchid Pharma Limited (ORCHPHARMA) — Financial Results

· NSE 🔴 High Importance Neutral
📢 Key Event
Analysts' earnings call scheduled for Q4FY26 and FY26 results discussion
💡 Investor Takeaway
Investors can attend the call to hear management discuss quarterly and annual financial performance.

Orchid Pharma announced an analysts' earnings call on May 26, 2026 at 4:30 PM IST to discuss Q4FY26 and FY26 results, hosted by Systematix Institutional Equities, with management representation from MDs and CFO, and will be accessible via dial-in numbers and webcast on the company website.

📄 View Original Announcement (PDF)

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day